Clinical Trials Browser

Phase 2 × Cystadenocarcinoma, Serous × niraparib × Clear all

NCT04716686 2024-01-05

Niraparib Monotherapy as Maintain and Recurrent Treatment of Endometrial Serous Carcinoma

Phase 2 Recruiting

Endometrial Neoplasms, Cystadenocarcinoma, Serous